A dried green alga taken daily in gram doses. Best-supported effects are modest: lower cholesterol, small drops in weight and body fat, better liver blood tests in fatty liver. Harms are mostly mild and digestive. The evidence is uneven; the effects are real but small. (Full Review)
| Marker | Target | Why |
|---|---|---|
| LDL cholesterol | 70-100 mg/dL | Primary responsive outcome |
| Total cholesterol | 150-200 mg/dL | Second responsive lipid outcome |
| Systolic / diastolic blood pressure | Below 120/75 mmHg | The effect is confined to those starting elevated |
| Fasting glucose | 75-86 mg/dL | Detects the marginal glycaemic signal |
| HbA1c | 4.8-5.3% | Confirms any glucose change is durable |
| Alanine aminotransferase | 10-26 U/L men, 10-19 U/L women | Best-replicated liver outcome |
| hs-CRP | Below 0.5 mg/L | Tracks the low-grade inflammation signal |
| Serum urate | 3.5-5.5 mg/dL | Primary safety measure for the purine load |
| Ferritin with transferrin saturation | 50-150 ng/mL and 25-35% | Safety measure for mineral depletion |
| Serum selenium | 120-150 µg/L | Second depletion measure |
| Vitamin B12 with methylmalonic acid | Above 500 pg/mL, with methylmalonic acid below 0.27 µmol/L | Tests for usable B12 |
| INR | The anticoagulation indication's own target, typically 2.0-3.0 | Detects the vitamin K interaction |
Cadence: Baseline panel before starting; home blood pressure daily for two weeks, then weekly; bloods at three months, then every six to twelve months. Anticoagulated users check clotting weekly until stable.